Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings yield high or low?
The earnings yield of 5.77% is in line with its 1-year average of 5.34%, near the high end of its 1-year range (4.85%–5.90%).
As of 2026-10-06T10:25:35.342Z.
Calculation as of: 2026-10-06T10:25:35.342Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 3b719543d2ad964e34cebd38a4954272106044749b474b483c00e469aab85807
EARNINGS YIELD
5.77%
EARNINGS YIELD AVG TTM
N/A
EARNINGS YIELD AVG 3Y
N/A
EARNINGS YIELD AVG 5Y
N/A
EARNINGS YIELD AVG 10Y
N/A
EARNINGS YIELD AVG 15Y
N/A
EARNINGS YIELD AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.55%
median of 110 covered companies
CURRENT VS SECTOR MEDIAN
+62.31%
vs the sector median at left
Market Cap
$14.97B
Earnings Yield
N/A
TTM Avg
3.33%
3Y Avg
3.92%
5Y Avg
3.29%
Market Cap
$13.19B
Earnings Yield
0.34%
TTM Avg
1.21%
3Y Avg
2.17%
5Y Avg
2.83%
Market Cap
$15.24B
Earnings Yield
9.30%
TTM Avg
10.22%
3Y Avg
8.35%
5Y Avg
8.35%
Market Cap
$12.89B
Earnings Yield
2.53%
TTM Avg
4.64%
3Y Avg
4.13%
5Y Avg
3.27%
Market Cap
$12.52B
Earnings Yield
N/A
TTM Avg
10.20%
3Y Avg
8.28%
5Y Avg
5.38%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ascendis Pharma A/S (ASND) | $14.16B | 5.77% | N/A | N/A | N/A |
| Tempus AI, Inc. (TEM)vs › | $14.64B | N/A | N/A | N/A | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.79B | 5.42% | 5.79% | 4.43% | 4.11% |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.97B | N/A | 3.33% | 3.92% | 3.29% |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.34% | 1.21% | 2.17% | 2.83% |
| Solventum Corporation (SOLV)vs › | $15.24B | 9.30% | 10.22% | 8.35% | 8.35% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | N/A | N/A | N/A | N/A |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 2.53% | 4.64% | 4.13% | 3.27% |
| Baxter International Inc. (BAX)vs › | $12.52B | N/A | 10.20% | 8.28% | 5.38% |
| Penumbra, Inc. (PEN)vs › | $12.49B | 1.28% | 1.35% | 0.85% | 0.69% |
Earnings Yield
5.77%
EPS ÷ Price
P/E Ratio
17.3
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS YIELD |
|---|---|
| 2026-10-05 | 5.77% |
| 2026-10-02 | 5.78% |
| 2026-10-01 | 5.79% |
| 2026-09-30 | 5.78% |
| 2026-09-29 | 5.77% |
| 2026-09-28 | 5.72% |
| 2026-09-25 | 5.83% |
| 2026-09-24 | 5.70% |
| 2026-09-23 | 5.90% |
| 2026-09-22 | 5.54% |
| 2026-09-21 | 5.54% |
| 2026-09-18 | 5.56% |
| 2026-09-17 | 5.51% |
| 2026-09-16 | 5.31% |
| 2026-09-15 | 5.49% |
| 2026-09-14 | 4.97% |
| 2026-09-11 | 4.99% |
| 2026-09-10 | 5.04% |
| 2026-09-09 | 5.05% |
| 2026-09-08 | 4.87% |
| 2026-09-04 | 4.86% |
| 2026-09-03 | 4.85% |
| 2026-09-02 | 4.92% |
| 2026-09-01 | 5.06% |
| 2026-08-31 | 5.00% |
| 2026-08-28 | 5.31% |
| 2026-08-27 | 5.28% |
| 2026-08-26 | 5.26% |
| 2026-08-25 | 5.20% |
| 2026-08-24 | 5.22% |
| 2026-08-21 | 5.20% |
| 2026-08-20 | 5.16% |
| 2026-08-19 | 5.07% |
| 2026-08-18 | 5.29% |
| 2026-08-17 | 5.32% |
| 2026-08-14 | 5.30% |
